Twitter (NYSE:TWTR) COO Ali Rowghani sold 20,551 shares of the company’s stock on the open market in a transaction dated Wednesday, July 2nd. The stock was sold at an average price of $42.43, for a total transaction of $871,978.93. Twitter Inc (NYSE:TWTR) stock performance was 1.74% in last session and finished the day at $38.06….
Ultragenyx Pharmaceutical Inc (NASDAQ:RARE) on July 9 announced the pricing of its underwritten public offering of 2,017,349 shares of its common stock at a price to the public of $40.00 per share, before underwriting discounts. Ultragenyx is selling 1,311,277 shares of its common stock in this offering, and certain selling stockholders are selling 706,072 shares…
CASI Pharmaceuticals, Inc. (NASDAQ:CASI), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and other diseases, announced today that its orally-active, Aurora A/angiogenic kinase inhibitor, ENMD-2076, has received Orphan Drug designation from the U.S. Food and Drug Administration (FDA) for the treatment of hepatocellular carcinoma (HCC). CASI Pharmaceuticals Inc (NASDAQ:CASI) stock performance was…
On June 12, 2014, Demand Media, Inc. (NYSE:DMD) held its 2014 Annual Meeting of Stockholders (the “Annual Meeting”). At the Annual Meeting, 84,630,271 shares were represented in person or by proxy, constituting approximately 93% of the Company’s outstanding shares as of April 21, 2014, the record date for the Annual Meeting. At the Annual Meeting,…
Gilead Sciences, Inc. (NASDAQ:GILD) on June 15 announced topline results from a Phase 3 clinical trial (GS-US-337-0113) in Japan evaluating the investigational once-daily fixed-dose combination of the NS5A inhibitor ledipasvir (LDV) 90 mg and the nucleotide analog polymerase inhibitor sofosbuvir (SOF) 400 mg, with and without ribavirin (RBV), for the treatment of genotype 1 chronic…
Opko Health (NYSE:OPK) CEO Phillip Md Et Al Frost purchased 30,000 shares of the stock in a transaction dated Tuesday, July 8th. The shares were purchased at an average price of $8.58 per share, for a total transaction of $257,400.00. Following the completion of the transaction, the chief executive officer now directly owns 1,987,500 shares…
Tech Analysis & Market News